Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke

Open source

DOI: 10.1007/s00204-023-03498-0
Published: 2023-05-06
Container: Archives of Toxicology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00204-023-03498-0,
  title = {Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities},
  author = {Joost Boeckmans and Alexandra Gatzios and Jörn M. Schattenberg and Robim M. Rodrigues and Vera Rogiers and Tamara Vanhaecke},
  year = {2023},
  journal = {Archives of Toxicology},
  doi = {10.1007/s00204-023-03498-0},
  url = {https://doi.org/10.1007/s00204-023-03498-0}
}

RIS

TY  - JOUR
TI  - Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities
AU  - Joost Boeckmans
AU  - Alexandra Gatzios
AU  - Jörn M. Schattenberg
AU  - Robim M. Rodrigues
AU  - Vera Rogiers
AU  - Tamara Vanhaecke
PY  - 2023
JO  - Archives of Toxicology
DO  - 10.1007/s00204-023-03498-0
UR  - https://doi.org/10.1007/s00204-023-03498-0
ER  -

APA

Boeckmans, J., Gatzios, A., Schattenberg, J. M., Rodrigues, R. M., Rogiers, V., & Vanhaecke, T. (2023). Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of Toxicology. https://doi.org/10.1007/s00204-023-03498-0

Source records

crossref · retrieved 2026-11-04T00:02:30.968Z